Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report

Global pandemic of Coronavirus disease 2019 (COVID-19) have been developed with a respiratory infection as main symptom and vaccines had been proven against SARS-CoV-2 infection. We would like to present acute transverse myelitis with hypercoagulable condition case, after receiving the inactive SARS...

Full description

Saved in:
Bibliographic Details
Main Author: Lisda Amalia
Format: Article
Language:Indonesian
Published: Indonesian Society of Neuroanesthesia & Critical Care (INA-SNACC) 2025-02-01
Series:Jurnal Neuroanestesi Indonesia
Subjects:
Online Access:https://inasnacc.org/ojs2/index.php/jni/article/view/631
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324456837644288
author Lisda Amalia
author_facet Lisda Amalia
author_sort Lisda Amalia
collection DOAJ
description Global pandemic of Coronavirus disease 2019 (COVID-19) have been developed with a respiratory infection as main symptom and vaccines had been proven against SARS-CoV-2 infection. We would like to present acute transverse myelitis with hypercoagulable condition case, after receiving the inactive SARS-CoV-2 vaccine (SinoVac). Case Presentation: This is a case from a 20-year-old male with acute onset of flaccid paraplegia, hyporeflexia, loss of sensation below 5th thoracic level, loss of autonomic function, and a positive Babinski sign bilaterally on 7 days after receiving SARS-CoV-2 vaccine. From lumbar puncture examination, we found elevated liquor cerebrospinal protein with mononuclear cell predominantly and elevated d-dimer and also decreased fibrinogen levels from laboratory examination. From Magnetic Resonance Imaging (MRI) showed hyperintensity at the 5th until 9th thoracal level. He improved motoric strength of the lower limb (walking without assistance), numbness and pain, urine and fecal retention after receiving methylprednisolone for 3 days. Conclusion: Acute transverse myelitis with hypercoagulable state was a rare case associated with COVID-19 vaccination, but clinician should be aware for early detection and giving proper treatment.
format Article
id doaj-art-39b9c37a834c48d0bb01aa8757451f80
institution Kabale University
issn 2088-9674
2460-2302
language Indonesian
publishDate 2025-02-01
publisher Indonesian Society of Neuroanesthesia & Critical Care (INA-SNACC)
record_format Article
series Jurnal Neuroanestesi Indonesia
spelling doaj-art-39b9c37a834c48d0bb01aa8757451f802025-08-20T03:48:42ZindIndonesian Society of Neuroanesthesia & Critical Care (INA-SNACC)Jurnal Neuroanestesi Indonesia2088-96742460-23022025-02-011412124https://doi.org/10.24244/jni.v14i1.631Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case ReportLisda Amalia0Department of Neurology, Medical Faculty, Universitas Padjadjaran/Hasan Sadikin General Hospital Bandung, IndonesiaGlobal pandemic of Coronavirus disease 2019 (COVID-19) have been developed with a respiratory infection as main symptom and vaccines had been proven against SARS-CoV-2 infection. We would like to present acute transverse myelitis with hypercoagulable condition case, after receiving the inactive SARS-CoV-2 vaccine (SinoVac). Case Presentation: This is a case from a 20-year-old male with acute onset of flaccid paraplegia, hyporeflexia, loss of sensation below 5th thoracic level, loss of autonomic function, and a positive Babinski sign bilaterally on 7 days after receiving SARS-CoV-2 vaccine. From lumbar puncture examination, we found elevated liquor cerebrospinal protein with mononuclear cell predominantly and elevated d-dimer and also decreased fibrinogen levels from laboratory examination. From Magnetic Resonance Imaging (MRI) showed hyperintensity at the 5th until 9th thoracal level. He improved motoric strength of the lower limb (walking without assistance), numbness and pain, urine and fecal retention after receiving methylprednisolone for 3 days. Conclusion: Acute transverse myelitis with hypercoagulable state was a rare case associated with COVID-19 vaccination, but clinician should be aware for early detection and giving proper treatment.https://inasnacc.org/ojs2/index.php/jni/article/view/631acute transverse myelitishypercoagulable state
spellingShingle Lisda Amalia
Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
Jurnal Neuroanestesi Indonesia
acute transverse myelitis
hypercoagulable state
title Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
title_full Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
title_fullStr Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
title_full_unstemmed Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
title_short Inactivated SARS–CoV–2 Vaccine Inducing Acute Transverse Myelitis and Hypercoagulable State: A Case Report
title_sort inactivated sars cov 2 vaccine inducing acute transverse myelitis and hypercoagulable state a case report
topic acute transverse myelitis
hypercoagulable state
url https://inasnacc.org/ojs2/index.php/jni/article/view/631
work_keys_str_mv AT lisdaamalia inactivatedsarscov2vaccineinducingacutetransversemyelitisandhypercoagulablestateacasereport